Cargando…
Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy
Osteosarcoma is the most common primary bone cancer affecting children and adolescents worldwide. Despite an incidence of three cases per million annually, it accounts for an inordinate amount of morbidity and mortality. While the use of chemotherapy (cisplatin, doxorubicin, and methotrexate) in the...
Autores principales: | Angulo, Pablo, Kaushik, Gaurav, Subramaniam, Dharmalingam, Dandawate, Prasad, Neville, Kathleen, Chastain, Katherine, Anant, Shrikant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219787/ https://www.ncbi.nlm.nih.gov/pubmed/28061797 http://dx.doi.org/10.1186/s13045-016-0373-z |
Ejemplares similares
-
Suppressing STAT5 signaling affects osteosarcoma growth and stemness
por: Subramaniam, Dharmalingam, et al.
Publicado: (2020) -
Cucurbitacin B and I inhibits colon cancer growth by targeting the Notch signaling pathway
por: Dandawate, Prasad, et al.
Publicado: (2020) -
Super-enhancers: novel target for pancreatic ductal adenocarcinoma
por: Ghosh, Chandrayee, et al.
Publicado: (2019) -
Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis
por: Subramaniam, Dharmalingam, et al.
Publicado: (2021) -
Targeting transcription factor TCF4 by γ-Mangostin, a natural xanthone
por: Krishnamachary, Balaji, et al.
Publicado: (2019)